Lumida
/SAGE
⌘K
SAGE Therapeutics Inc

SAGE Therapeutics Inc

SAGE
$8.68USD-0.23%-0.02 today

MARKET CAP

545.0M

P/E (TTM)

FWD P/E

DAY RANGE

$9 – $9

52W RANGE

$5
$11
STATEMENT·Income statement
USD · GAAP
METRICFY 2020FY 2021FY 2022FY 2023FY 2024TREND
Sales, Adj.$6.3M$6.3M$7.7M$86.5M$41.2M
YoY %-8.2%+21.8%+1024.8%-52.3%
P / Sales
EV / Sales
Gross Profit, Adj.$5.8M$5.8M$6.9M$84.3M$31.8M
YoY %-11.0%+19.4%+1126.5%-62.3%
Margin %91.2%91.2%89.4%97.5%77.1%
EV / Gross Profit
EBITDA, Adj.$-460.9M$-460.9M$-545.9M$-545.1M$-409.5M
YoY %+34.7%-18.4%+0.1%+24.9%
Margin %-7306.7%-7306.7%-7102.1%-630.5%-992.9%
EV / EBITDA
EBIT$-460.9M$-460.9M$-547.0M$-579.8M$-432.4M
YoY %+34.9%-18.7%-6.0%+25.4%
Margin %-7306.7%-7306.7%-7116.7%-670.7%-1048.3%
EV / EBIT
Net Income$-457.9M$-457.9M$-532.8M$-541.5M$-400.7M
YoY %+32.7%-16.4%-1.6%+26.0%
Net Margin-7258.9%-7258.9%-6931.9%-626.3%-971.5%
EPS (GAAP)-$7.80-$7.80-$8.98-$9.05-$6.59
YoY %+41.7%-15.1%-0.8%+27.2%